Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.81 USD | +1.12% | -7.65% | -48.32% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 9.594 | 179 | 53.87 | 33.1 | 5.453 | 4.118 | - | - |
Enterprise Value (EV) 1 | 9.594 | 179 | 53.87 | 33.1 | 5.453 | 4.118 | 4.118 | 4.118 |
P/E ratio | -0.31 x | -6.26 x | -1.67 x | -1.07 x | -1.59 x | -0.4 x | -0.37 x | -4.36 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | 156 x | - | 0.45 x | - | - | 0.13 x |
EV / Revenue | - | - | 156 x | - | 0.45 x | - | - | 0.13 x |
EV / EBITDA | - | - | - | - | - | - | - | - |
EV / FCF | - | -10,672,538 x | -2,441,646 x | - | - | - | - | - |
FCF Yield | - | -0% | -0% | - | - | - | - | - |
Price to Book | - | - | 4.6 x | - | - | - | - | - |
Nbr of stocks (in thousands) | 205 | 765 | 972 | 1,111 | 1,557 | 2,275 | - | - |
Reference price 2 | 46.80 | 234.0 | 55.40 | 29.80 | 3.502 | 1.810 | 1.810 | 1.810 |
Announcement Date | 2/27/20 | 2/25/21 | 3/15/22 | 3/8/23 | 3/5/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | 0.346 | - | 12.04 | - | - | 31.99 |
EBITDA | - | - | - | - | - | - | - | - |
EBIT 1 | -22.3 | -16.22 | -28.35 | -27.89 | -9.273 | -16.11 | -21.5 | -3.714 |
Operating Margin | - | - | -8,192.77% | - | -76.99% | - | - | -11.61% |
Earnings before Tax (EBT) 1 | -22.67 | -16.78 | -28.67 | -29.14 | -3.588 | -20.22 | -22.83 | -10.88 |
Net income 1 | -22.67 | -16.78 | -28.67 | -29.14 | -3.588 | -16.11 | -21.5 | -3.714 |
Net margin | - | - | -8,285.26% | - | -29.79% | - | - | -11.61% |
EPS 2 | -149.4 | -37.40 | -33.20 | -27.80 | -2.200 | -4.520 | -4.930 | -0.4150 |
Free Cash Flow | - | -16.77 | -22.06 | - | - | - | - | - |
FCF margin | - | - | -6,376.01% | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 2/27/20 | 2/25/21 | 3/15/22 | 3/8/23 | 3/5/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | 9 | - | 3.045 | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -6.881 | -7.663 | -9.446 | -6.239 | -6.377 | -5.832 | -7.313 | -0.779 | -1.588 | 0.407 | -2.682 | -2.778 | -2.955 | -3.582 |
Operating Margin | - | - | - | - | - | - | - | -8.66% | - | 13.37% | - | - | - | - |
Earnings before Tax (EBT) | -6.952 | -7.712 | -9.473 | -6.23 | -6.435 | -6.997 | -8.504 | -6.286 | 10.76 | 0.439 | - | - | - | - |
Net income 1 | -6.952 | -7.712 | -9.473 | -6.23 | -6.435 | -6.997 | -8.504 | -6.286 | 10.76 | 0.439 | -2.682 | -2.778 | -2.955 | -3.582 |
Net margin | - | - | - | - | - | - | - | -69.84% | - | 14.42% | - | - | - | - |
EPS 2 | -7.600 | -8.000 | -9.600 | -6.200 | -6.000 | -6.200 | -7.200 | -4.000 | 5.800 | 0.2000 | -1.180 | -0.9900 | -0.8700 | -1.050 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/3/21 | 3/15/22 | 5/11/22 | 8/10/22 | 11/14/22 | 3/8/23 | 5/10/23 | 8/14/23 | 11/9/23 | 3/5/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow | - | -16.8 | -22.1 | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | 12.00 | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | - | 0.05 | - | - | - | - | - |
Capex / Sales | - | - | 13.87% | - | - | - | - | - |
Announcement Date | 2/27/20 | 2/25/21 | 3/15/22 | 3/8/23 | 3/5/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.32% | 4.12M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- TCON Stock
- Financials TRACON Pharmaceuticals, Inc.